|
|
| Nomenclature |
|
Symbol:
|
Tg(INS-cre)2Rms
|
|
Name:
|
transgene insertion 2, Robyn M Slattery
|
|
MGI ID: |
MGI:2663956 |
|
Synonyms: |
HIP-Cre |
|
Transgene:
|
Tg(INS-cre)2Rms
Location:
unknown
|
|
Transgene
origin |
|
Transgene
description |
|
Transgene
Type: | |
Transgenic (Cre/Flp) |
|
Mutation: | |
Insertion |
| |
|
Mutation details: The transgene consists of a human insulin promoter and cre. The human insulin promoter (INS) drives cre expression in beta islet cells. (J:83635)
|
|
|
Recombinase activity
|
|
Driver:
|
INS
Summary of all recombinase alleles
driven by INS.
|
|
MGI has not yet included tissue activity data for this allele in any anatomical systems.
|
|
Phenotypes
|
View phenotypes for all genotypes (concatenated display).
|
|
Disease models
|
|
| Find Mice (IMSR) |
Mouse strains and cell lines available from the
International Mouse Strain Resource
(IMSR)
|
Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available |
|
| References |
|
Original: |
J:83635
Hamilton-Williams EE et al.,
"Beta cell MHC class I is a late requirement for diabetes."
Proc Natl Acad Sci U S A 2003 May 27;100(11):6688-93
|
|
All: |
1 reference(s)
|
|
Analysis Tools
